Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jan 2019. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3524517019 | Product containing cytarabine liposome (medicinal product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
3524519016 | Product containing cytarabine liposome | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3668631019 | Cytarabine liposome product | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
98580401000001113 | Cytarabine (liposomal) | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing cytarabine liposome | Is a | Product containing cytarabine | false | Inferred relationship | Existential restriction modifier | ||
Product containing cytarabine liposome | Has active ingredient | Cytarabine liposome | false | Inferred relationship | Existential restriction modifier | ||
Product containing cytarabine liposome | Is a | Product containing phospholipid | false | Inferred relationship | Existential restriction modifier | ||
Product containing cytarabine liposome | Is a | Virtual therapeutic moiety | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Cytarabine liposomal 50mg/5mL injection 5mL vial | Is a | False | Product containing cytarabine liposome | Inferred relationship | Existential restriction modifier | |
Cytarabine 50mg/5ml intrathecal suspension for injection vials | Is a | False | Product containing cytarabine liposome | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets